ClinicalTrials.Veeva

Menu

The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status and phase

Unknown
Phase 4

Conditions

Colon Polyps
Bifidobacteri
Combizym

Treatments

Drug: Combizym + Bifidobacteri
Drug: Combizym
Drug: Bifidobacteri

Study type

Interventional

Funder types

Other

Identifiers

NCT02097394
RJYYXHNK-002

Details and patient eligibility

About

The study hypothesis is whether digestion enzyme(Combizym) and intestinal flora drugs(Bifidobacteria) can decease recurrence rate of colon polyps

Full description

Colon polyps has high recurrence rate in the digestion diseases. However, the reasons are not clear. The possible reasons for the recurrence of colon polyps include intestinal inflammation (e.g., Ulcerative colitis), intestinal flora imbalance (the benefit intestinal bacteria reduced, which lead to diarrhea or constipation), long-term indigestion. The investigators propose to examine whether digestion enzyme (Combizym) and intestinal flora drugs(Bifidobacteria) can decease recurrence rate of colon polyps

Enrollment

200 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Patients who have cutted colon polyps in one month, and the diagnosis were proved by pathological analysis

Exclusion criteria

  • have organic or other functional disease
  • pregnant or breast-feeding

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 4 patient groups

Combizym-treated group
Active Comparator group
Description:
The patients who received polypectomy of colon polyps take the digestion enzyme (Combizym) regularly.
Treatment:
Drug: Combizym
Bifidobacteri-treated group
Active Comparator group
Description:
The patients who received polypectomy of colon polyps take Bifidobacteri regularly
Treatment:
Drug: Bifidobacteri
Combizym + Bifidobacteri-treated group
Active Comparator group
Description:
The patients who received polypectomy of colon polyps take drugs (Combizym + Bifidobacteri) regularly
Treatment:
Drug: Combizym + Bifidobacteri
control
No Intervention group
Description:
The patients who received polypectomy of colon polyps take no drugs

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems